<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04584879</url>
  </required_header>
  <id_info>
    <org_study_id>53545</org_study_id>
    <nct_id>NCT04584879</nct_id>
  </id_info>
  <brief_title>Transdiagnostic Treatment Personalization</brief_title>
  <official_title>Transdiagnostic Treatment Personalization: Prioritizing Therapy Components to Capitalize on Strengths or Compensate for Weaknesses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shannon E. Sauer-Zavala</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kentucky</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to explore whether the efficiency of treatment for&#xD;
      anxiety and depressive disorders can be increased using two discrete strategies: personalized&#xD;
      skill ordering and 2) treatment discontinuation based on proximal indicators of improvements.&#xD;
      The present study will specifically use treatment components drawn from an evidence-based&#xD;
      psychological intervention, the Unified Protocol for the Transdiagnostic Treatment of&#xD;
      Emotional Disorders (UP). This intervention has strong empirical support for patients&#xD;
      presenting with anxiety, depressive, and related disorders and contains therapeutic skills&#xD;
      that are common in psychological interventions (e.g., psychoeducation, mindfulness training,&#xD;
      cognitive restructuring, countering emotional avoidance, increasing interoceptive tolerance).&#xD;
      This study will determine if prioritizing the order of treatment modules to capitalize on&#xD;
      patient strengths or compensate for weakensses increases treatmen efficacy. Additionally, it&#xD;
      will also identify under what conditions briefer treatment modules may be appropriate.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 28, 2019</start_date>
  <completion_date type="Actual">September 15, 2020</completion_date>
  <primary_completion_date type="Actual">September 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Clinical Severity</measure>
    <time_frame>12 weeks (baseline, week 6 and week 12)</time_frame>
    <description>Clinical severity will be measured using the Diagnostic Interview for Anxiety, Mood, and Obsessive Compulsive and Related Neuropsychiatric Disorders (DIAMOND) dimensional clinician ratings. Scores range from 1-7; higher scores indicate greater severity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Anxiety Symptoms</measure>
    <time_frame>12 weeks (baseline, week 1, week, 2, week, 3.....week 12)</time_frame>
    <description>Anxiety symptoms will be measured using the Overall Anxiety Severity and Interference Scale (OASIS). This is a self-report measure in which scores range from 0-20; higher scores indicate more severe anxiety symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Depressive Symptoms</measure>
    <time_frame>12 weeks (baseline, week 1, week, 2, week, 3.....week 12)</time_frame>
    <description>Depressive symptoms will be measured using the Overall Depression Severity and Interference Scale (ODSIS). This is a self-report measure in which scores range from 0-20; higher scores indicate more severe anxiety symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Aversive Reactions to Emotions</measure>
    <time_frame>12 weeks (baseline, week 1, week, 2, week, 3.....week 12)</time_frame>
    <description>Aversive reactions to emotions will be measured using the distress aversion subscale of the Multidimensional Experiential Avoidance Questionnaire (MEAQ). This is a self-report measure in which scores range from 13-78; higher scores indicate greater negative reactions to emotional experiences.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Anxiety Disorders</condition>
  <condition>Depressive Disorder</condition>
  <condition>Post Traumatic Stress Disorder</condition>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>Standard Group, Brief Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive 6 sessions of treatment in accordance with the standard, published Unified Protocol (UP) manual.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Group, Full Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive 12 sessions of treatment in accordance with the standard, published Unified Protocol (UP) manual.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Capitalization Group, Brief Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive 6 sessions of treatment organized to prioritize skills that capitalize on patient strengths.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Capitalization Group, Full Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive 12 sessions of treatment organized to prioritize skills that capitalize on patient strengths.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Compensation Group, Brief Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive 6 sessions of treatment organized to prioritize skills that compensate for patient weaknesses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Compensation Group, Full Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive 12 sessions of treatment organized to prioritize skills that compensate for patient weaknesses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard UP Treatment</intervention_name>
    <description>Participants will receive treatment modules sequenced in accordance with the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (UP; Barlow et al 2011; 2018).</description>
    <arm_group_label>Standard Group, Brief Intervention</arm_group_label>
    <arm_group_label>Standard Group, Full Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Capitalization UP Treatment</intervention_name>
    <description>Participants will receive Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (UP) treatment modules organized to prioritize skills that capitalize on patient strengths.</description>
    <arm_group_label>Capitalization Group, Brief Intervention</arm_group_label>
    <arm_group_label>Capitalization Group, Full Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Compensation UP Treatment</intervention_name>
    <description>Participants will receive Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (UP) treatment modules organized to prioritize skills that compensate for patient weaknesses.</description>
    <arm_group_label>Compensation Group, Brief Intervention</arm_group_label>
    <arm_group_label>Compensation Group, Full Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of at least one emotional disorder&#xD;
&#xD;
          -  fluent in English&#xD;
&#xD;
          -  medication stability&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  concurrent therapy&#xD;
&#xD;
          -  psychological condition that would be better addressed by alternative treatments&#xD;
&#xD;
          -  have received more than 5 sessions of cognitive behavioral therapy in the past 5 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shannon Sauer-Zavala</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kentucky</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 6, 2020</study_first_submitted>
  <study_first_submitted_qc>October 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Kentucky</investigator_affiliation>
    <investigator_full_name>Shannon E. Sauer-Zavala</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Unified Protocol</keyword>
  <keyword>Cognitive Behavioral Therapy</keyword>
  <keyword>Personalization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

